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Campylobacter jejuni is a worldwide cause of human diarrhoeal disease. Clustered
Repetitively Interspaced Palindromic Repeats (CRISPRs) and associated proteins
allow Bacteria and Archaea to evade bacteriophage and plasmid infection. Type II
CRISPR systems are found in association with combinations of genes encoding the
CRISPR-associated Cas1, Cas2, Cas4 or Csn2, and Cas9 proteins. C. jejuni possesses
a minimal subtype II-C CRISPR system containing cas1, cas2, and cas9 genes whilst
cas4 is notably absent. Cas4 proteins possess 5′-3′ exonuclease activity to create
recombinogenic-ends for spacer acquisition. Here we report a conserved Cas4-like
protein in Campylobacter bacteriophages that creates a novel split arrangement between
the bacteriophage and host that represents a new twist in the bacteriophage/host
co-evolutionary arms race. The continuous association of bacteriophage and host in the
carrier state life cycle of C. jejuni provided an opportunity to study spacer acquisition in
this species. Remarkably all the spacer sequences observed were of host origin. We
hypothesize that Campylobacter bacteriophages can use Cas4-like protein to activate
spacer acquisition to use host DNA as an effective decoy to bacteriophage DNA. Bacteria
that acquire self-spacers and escape phage infection must overcome CRISPR-mediated
autoimmunity either by loss of the interference functions leaving them susceptible to
foreign DNA incursion or tolerate changes in gene regulation.
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INTRODUCTION
CRISPR systems constitute a rudimentary immune system for
prokaryotes that enables them to survey, adapt and inacti-
vate invading pathogens and parasites (Horvath and Barrangou,
2010). Three distinct CRISPR types are recognized (Types I–
III), which comprise of various proteins and ribonucleopro-
tein complexes that concertedly mediate the capture of short
DNA sequences (protospacers) from invasive genomes, such
as those represented on bacteriophages (phages) and plasmids
(Sorek et al., 2013; Spilman et al., 2013; Fonfara et al., 2014).
Foreign DNA elements are incorporated into a CRISPR array
as spacer DNA sequences flanked by conserved direct repeats.
CRISPR-associated (cas) genes are frequently located within the
immediate vicinity of an array, which encode proteins with
endo/exonuclease activities required for protospacer acquisition.
All CRISPR systems encode Cas1 DNA endonucleases and Cas2
RNA endonucleases that function to generate dsDNA protospac-
ers of ∼30–50 bp in size (Shah et al., 2013; Sorek et al., 2013).
Upon integration into the array the spacers are expressed as
small antisense CRISPR RNA molecules (crRNAs) that serve to
guide proteins such as Cas3 (Type I CRISPR) and Cas9 (Type
II CRISPR) to their intended targets during subsequent reinfec-
tion events (Marraffini, 2013). This process is termed CRISPR
interference, the ultimate consequence of which is cleavage of the
foreign DNA molecule thus protecting the bacterium/archaeon
from the attempted infection event (Marraffini and Sontheimer,
2010).
Type II CRISPR systems are characterized by the presence of
genes encoding various configurations of Cas1, Cas2, Cas4, and
Cas9 proteins accompanied by a trans-activated CRISPR RNA
(tracrRNA). Subtype II-A CRISPR systems found in Streptococcus
spp. also contain the genes csn2a/csn2b (Fonfara et al., 2014). The
minimal nature of Type II CRISPR systems requires that they
use host RNase III during the biogenesis of crRNA molecules
(Sampson and Weiss, 2013; Sorek et al., 2013). Campylobacter
jejuni NCTC 11168 and C. jejuni PT14 are reported to con-
tain subtype II-C CRISPR systems comprising of Cas1, Cas2,
Cas9 proteins and a tracrRNA, whilst no homolog of Cas4 has
been identified (Dugar et al., 2013; Brathwaite et al., 2013).
Following Cas1/Cas2-mediated protospacer capture and subse-
quent crRNA biogenesis, a dsRNA molecule comprised of crRNA
and tracrRNA (complementary base-paired at the 3′-end of the
antisense crRNA) serves to target Cas9 endonuclease to the invad-
ing DNA element. Whilst not present in every characterized Type
II CRISPR system, it has recently been shown that Cas4 pro-
teins of subtype II-B systems possess 5′-3′ exonuclease activity
and are involved in the adaptation process of CRISPR immu-
nity (Zhang et al., 2012; Lemak et al., 2013). The generation
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of ssDNA 3′-ends by Cas4 produces potentially recombinogenic
3′-overhangs that allow strand invasion-mediated incorporation
of the captured protospacer into the CRISPR array. Cas4 pro-
teins have a number of signature motifs that are observed to be
structurally similar to the AddB exonuclease component of the
AddAB helicase/exonuclease complex found in Bacillus subtilis
(Saikrishnan et al., 2012). The crystal structure of Cas4 SsO0001
from Sulfolobus solfataricus has recently been reported to be a
decameric toroidal structure formed by the interactions of five
Cas4 dimers (Lemak et al., 2013). Each Cas4 protein contains a
4Fe-4S binding cluster and a bound Mn2+ molecule is predicted
to occupy the active site of each monomer. Cas4 proteins contain
four absolutely conserved cysteine residues that form the 4Fe-4S
cluster (Zhang et al., 2012; Lemak et al., 2013) with conserved
domains and motifs present in a wide range of RecB exonucleases
to which they are related (Sisáková et al., 2008).
Due to the intricate associations that have guided the evo-
lutionary pathways of bacteria and their phages, it is of little
surprise that phages have evolved mechanisms to evade targeting
by host CRISPR systems. The complexity of these systems range
from single nucleotide polymorphisms in protospacer-adjacent
motif (PAM) sequences of phage 2972 that circumvent CRISPR-
mediated immunity by Streptococcus thermophilus DGCC7710
(Sun et al., 2013), to the specific prophage-encoded anti-CRISPR
proteins found in Mu-like phages that infect Pseudomonas aerug-
inosa PA14 (Bondy-Denomy et al., 2013). In a role reversal
Vibrio cholerae-specific Myoviridae phages contain a complete
Type I-F CRISPR system that overcomes the anti-phage activ-
ity of a host encoded pathogenicity island (Seed et al., 2013).
Here we report a unique phage-encoded Cas4-like protein in
Campylobacter phages. Bioinformatic analysis suggests that the
protein is structurally similar to Cas4 (SsO0001) of S. solfatar-
icus and contains four conserved cysteines associated with 4Fe-
4S cluster formation, and conserved RecB exonuclease motifs.
Interestingly, protein homologs are found distributed through-
out all Class II (Cp220likevirus) and Class III (Cp8unalikevirus)
Campylobacter phages that compose the Eucampyvirinae (Javed
et al., 2014). The Type II-C CRISPR systems of C. jejuni notably
lack Cas4 proteins. The absence of cas4 may hinder spacer acqui-
sition including bacteriophage defense but the recoupling of
the cas4 component results in the incorporation of self-derived
Campylobacter DNA with the potential to modify host gene
expression and evolution within the species as a response to these
changes.
MATERIALS AND METHODS
BACTERIA AND BACTERIOPHAGES
C. jejuni PT14 was routinely grown on horse blood agar at
42◦C under microaerobic conditions (85% N2, 5% O2 and
10% H2) for 18 h as previously described (GenBank acces-
sion CP003871; Brathwaite et al., 2013). Class III bacterio-
phages CP8 and CP30A were isolated and propagated as
described previously (respective GenBank accessions KF148616
and JX569801; Loc Carrillo et al., 2005). Carrier state
Campylobacter cultures PT14CP8CS and PT14CP30ACS were
formed and propagated as described previously (Siringan et al.,
2014).
DNA SEQUENCING
Genomic DNAs were prepared from C. jejuni PT14 and carrier
state cultures propagated on blood agar plates using GenElute™
(Sigma-Aldrich, Dorset, UK), from which 5 to 7 million 100
bp reads were generated using MiSeq technology operating in
paired-end mode (Illumina, San Diego, California, USA) and
imported into CLC Genomics Workbench 6.0 for analysis.
BIOINFORMATICS
Database searches were conducted using the BLAST suite of pro-
grams at NCBI (Camacho et al., 2009). Protein sequence align-
ments and phylogenetic trees were calculated using ClustalW2
(McWilliam et al., 2013). Protein structure models were created
and superimposed using the Phyre2 server (Kelley and Sternberg,
2009).
TRANSCRIPTOME ANALYSIS
Total RNAs were extracted from three independent early-log
phase cultures of C. jejuni PT14 growing in Mueller-Hinton
broth (Oxoid, Basingstoke, UK), using TRIzol® Max™ with
Max™ Bacterial Enhancement Reagent (Invitrogen, Paisley, UK)
and depleted of rRNA using Ribo-Zero™ rRNA removal kit
for Gram negative bacteria (Epicentre Biotechnologies, Madison,
Wisconsin, USA). Aliquots were incubated with Terminator™
5′-monophosphate-dependent exonuclease (TEX) (Epicentre
Biotechnologies) to remove processed RNAs. cDNA libraries were
prepared with TruSeq™ RNA (Illumina) and adapter indexed
and run on Illumina MiSeq operating in single-read mode. Raw
sequence reads were imported into CLC Genomics Workbench
6.0 for analysis. Differential expression was determined using
the RPKM expression values in conjunction with Baggerly’s test
statistic (Baggerly et al., 2003) using a False Discovery Rate (FDR)
correction (Benjamini and Hochberg, 1995).
RESULTS
CAMPYLOBACTER BACTERIOPHAGES HARBOR CRISPR Cas4-LIKE
PROTEINS
Bioinformatic analysis of the genome of Campylobacter phage
CP8 revealed the presence of a hitherto unannotated gene of
732 bp that initiates using a GUG codon and encodes a putative
243 amino acid Cas4-like protein (predicted molecular weight
28.8 kDa.). The gene is highly conserved amongst other Class III
Campylobacter phages (CPX, CP30A, NCTC 12673, and CP81)
although BLASTN reveals no other significant similarities outside
of the phage class. Translation reveals diverged protein homologs
exist in Class II Campylobacter phages CP220, CP21, and Cpt10 as
well as many bacterial proteins. The domain architecture of CP8
Cas4-like protein is strikingly similar to other proteins recognized
as belonging to the Cas4 family with a number of signature motifs
distributed throughout the protein. Bacteriophage CP8 Cas4-like
protein can be structurally aligned with Cas4 protein (SsO0001)
of Sulfolobus solfataricus (99.75% confidence). Figure 1A shows
the absolute conservation of cysteine residues C12, C223, C226,
and C232 that correspondwith a highly ordered 4Fe-4S iron bind-
ing domain. A RecB EXXXXXL motif I (ECFRQCKL) is located
at residues 11–18 of the CP8 Cas4-like protein, the first cysteine
in this motif corresponding with the N-terminal C12 residue of
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FIGURE 1 | Structural conservation of the C-terminal 4Fe-4S
cluster-forming cysteines of Cas4-like proteins from Campylobacter
phages. (A) The predicted structure of the bacteriophage CP8 Cas4-like
protein monomer from Phyre2 indicating the amino acid positions of the four
conserved cysteine residues that form a 4Fe-4S cluster; (B) Arrangement of
the monomer structures within the decameric toroidal Cas4 protein
(SsO0001) of S. solfataricus showing positions of the 4Fe-4S clusters (13); (C)
Phylogenetic analysis using a neighboring-joining tree without distance
correction (ClustalW2) revealing lated family of proteins where Class III phage
Cas4-like proteins cluster with C. fetus, C. concisus and SsO0001.
the 4Fe-4S cluster. A PD(D/E)XK (PDDDK) nuclease domain is
observed to span residues 111–121, a QXXXY motif (QLALY) is
found at residues 156–160, whilst the three C-terminal conserved
cysteines are located from residues 223–232. In silico mutational
analysis of the conserved cysteines indicates the importance of
these amino acids with regards to the function of the 4Fe-4S
cluster and the integrity of the quaternary decameric structure
(Figure 1B). In Class II and Class III Campylobacter phages,
the four cysteine residues forming the Fe-S cluster are highly
conserved despite significant divergence in total amino acid com-
position. ClustalW2 alignments using Class II and Class III
Campylobacter phage Cas4-like amino acid sequences show that
the EXXXXXXL motif, PD(D/E)XK nuclease domain, QXXXY
motif, and the four cysteine residues are all conserved in these
proteins. A phylogenetic tree demonstrating the relationship
between the Campylobacter phage Cas4-like proteins and Cas4
proteins of S. solfataricus, C. concisus UNSW2 and C. fetus 03-
427T is presented in Figure 1C. Class III Campylobacter phages
cluster as a sub-branch of the Cas4 proteins, whilst Class II
Campylobacter phages form a distinct branch.
THE CRISPR ARRAY OF C. JEJUNI PT14
The genome sequence of C. jejuni PT14 contains a minimal type
II-C CRISPR array organized in four 36 bp direct repeats flank-
ing three 30 bp spacer elements. Beginning 144 bp upstream of
the terminal direct repeat are the genes encoding the CRISPR-
associated proteins Cas2 (A911_07325), Cas1 (A911_07330), and
Cas9 (A911_07335). BLASTN analysis of the 36 bp direct repeats
shows that they are highly conserved and present in a large
number of C. jejuni CRISPR systems. The spacers within the
C. jejuni PT14 CRISPR array show no obvious matches to for-
eign DNA, and instead harbor nucleotide sequences that can
be mapped to the PT14 chromosome. Table 1 summarizes the
sequence matches observed for spacers 1 and 2, whereas only
short regions of homology (<12 nucleotides) can be identified
between spacer 3 and the PT14 chromosome. Spacers 1 and 3 are
also represented in the CRISPR arrays of C. jejuni strains R122,
R35, and FO14.
The organization of the C. jejuni PT14 CRISPR array is similar
to other C. jejuni in that the CRISPR array is located follow-
ing the reading frame of moaA (A911_07320) with a leader
sequence that contains a putative −10 nucleotide transcriptional
start site (5′-TAAAAT-3′) before the start of pre-crRNA synthe-
sis located 116 nucleotides upstream of the initial direct repeat
of the CRISPR array. As reported previously each direct repeat
in the CRISPR array contains an independent promoter such
that a single RNase III/tracrRNA dependent processing event is
required to create the mature crRNA (Dugar et al., 2013). The
direct repeats contain the motif 5′-GGTAAAAT-3′ that resembles
an extended −10 nucleotide transcriptional start site signal that
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Table 1 | Native and acquired spacer DNAs of the CRISPR array of C. jejuni PT14.
Spacer sequencea Frequencyb PAMc Target strandd Match Gene product Locus tag
NATIVE C. JEJUNI PT14 SPACERS 1-3
ATAATTTCTAATTTCATTTATAACCTTTCA 1 AAG + (18/30)PT14 Peptidoglycan-associated
lipoprotein Omp18
A911_00540
TAGTAGCTAAGAATAAAATAAGAAACACTG 1 TTC + (16/30)PT14 Apolipoprotein N
acyltransferase
A911_05300
TAGTAGCTAAGAATAAAATAAGAAACACTG CCA + (15/30)PT14 IleS—isoleucyl tRNA
synthetase
A911_05135
GTTGGAATGCTTAAGCAGGGGTGGAGTGAA 1 CAT − (12/30)PT14 Di/tripeptide transporter A911_03195
RE-ACQUIRED SPACER 3 (CS30)
GTTGGAATGCTTAAGCAGGGGTGGAGTGAA 6.1 × 10−2
ATTGGAATGCTTAAGCAGGGGTGGAGTGAA 1.8 ×10−3
GATGGAATGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GGTGGAATGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTAGAATGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−3
GTTTGAATGCTTAAGCAGGGGTGGAGTGAA 9.1 ×10−4 TTT − (14/30)PT14 Hypothetical protein A911_02745
GTTGGGATGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAGTGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAAAGCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4 TTT − (13/30)PT14 ATP-binding subunit ClpA
protease
A911_05365
GTTGGAACGCTTAAGCAGGGGTGGAGTGAA 1.8 × 10−3 TTT − (13/30)PT14 Intergenic A911_04960
GTTGGAATACTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAATTCTTAAGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAATGCTCAAGCAGGGGTGGAGTGAA 1.8 × 10−3
GTTGGAATGCTTGAGCAGGGGTGGAGTGAA 9.1 × 10−4 AAC − (13/30)PT14 Citrate synthase A911_08105
GTTGGAATGCTTAGGCAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAATGCTTAAACAGGGGTGGAGTGAA 9.1 × 10−4
GTTGGAATGCTTAAGTAGGGGTGGAGTGAA 1.8 × 10−3
GTTGGAATGCTTAAGCGGGGGTGGAGTGAA 1.8 × 10−3
GTTGGAATGCTTAAGCAAGGGTGGAGTGAA 3.2 × 10−3
GTTGGAATGCTTAAGCAGAGGTGGAGTGAA 2.7 × 10−3
GTTGGAATGCTTAAGCAGTGGTGGAGTGAA 1.8 × 10−3
GTTGGAATGCTTAAGCAGGAGTGGAGTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGAGGAGTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGCGGAGTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGGGTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGACTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGATTGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGAGCGAA 1.8 × 10−3
GTTGGAATGCTTAAGCAGGGGTGGAGGGAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGAGTAAA 9.1 × 10−4
GTTGGAATGCTTAAGCAGGGGTGGAGTGAG 9.1 × 10−4
CS8 ACQUIRED NAIVE SPACERS
TAAAAATTTAAGCCCGCAAAGTCAAATTTC 5.5 × 10−4 ATC − (30/30)PT14 Hemin binding protein A911_07785
TGCTTAAATCCCCAAGTTTTTCTAAAAATT 5.5 × 10−4 GAG + (30/30)PT14 Conserved membrane
protein
A911_02540
TTATCTCCTTCTCCATCTCCATTATTATAA 5.5 × 10−4 TGC − (30/30)PT14 Hemolysin
activation/secretion
protein
A911_04705
TAAAATCTTTAAAATATTCTAAATTTTTTT 1.1 × 10−3 CAC + (30/30)PT14 PseE motility associated
protein
A911_06495
TCAAATACTTTTATGCTTTATGATACATTT 1.1 × 10−3 CAA − (30/30)PT14 Capsular polysaccharide
biosynthesis
A911_06909
CGCTAAGTTTTACAACTACTCAATTTTTAG 5.5 × 10−4 CCG − (29/30)PT14 L-Lactate permease A911_00360
(Continued)
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Table 1 | Continued
Spacer sequencea Frequencyb PAMc Target strandd Match Gene product Locus tag
TAAGATCTTCCAAGCTATGGCTTGAAATTT 5.5 × 10−4 TAC − (29/30)PT14 tRNA mo(5)U34
methyltransferase
A911_04710
TTGTAGCGTCTAAAATTTCATTTTTTTCAA 5.5 × 10−4 TTA + (28/30)PT14 Isocitrate dehydrogenase A911_02585
CS30 ACQUIRED NAIVE SPACERS
TAGAGCTTGTTTATAACGGGATAGTTTATT 9.1 × 10−4 TCT + (30/30)PT14 ADP-heptose-LPS
heptosyltransferase II
A911_05560
CAATAATCAATCTCAACTCCACTCCTATCA 4.5 × 10−4 TCC + (30/30)PT14 CRISPR-associated
protein Cas8c/Csd1
A911_05640
CTTTGCTTTTTGGATAATCAGAGAGGAAGA 4.5 × 10−4 CAA − (30/30)PT14 argF ornithine
carbamoyltransferase
A911_04795
TGGCTTCATATTTGATATAAGTACCACGAT 4.5 × 10−4 ATG + (30/30)PT14 Putative tungsten
ABC-transport system
A911_07415
GGCATTATTGAGCTGGTGTTTGCTCTTTTG 9.1 × 10−4 CAG + (30/30)PT14 Conserved hypothetical
protein
A911_00810
GCTGGTGTTTGCTCTTTTGTTTTTTTGTGA 4.5 × 10−4 TCA + (30/30)PT14 Conserved hypothetical
protein
A911_00810
ATAGAGCTTGTTTATAACGGGATAGTTTTT 4.5 × 10−4 CTT + (29/30)PT14 ADP-heptose-LPS
heptosyltransferase II
A911_05560
CTGATACTCAACTATTTTAAAGGAATTCCA 4.5 × 10−4 CAT + (29/30)PT14 Translation elongation
factor P
A911_02685
TGGCTCTAAAACTCCGCTCATATAAACCAA 4.5 × 10−4 CTT + (29/30)PT14 Anaerobic
C4-dicarboxylate
transporter
A911_00415
TCTATATCTTTTTTAAAATTTTTAATCTAA 9.1 × 10−4 AAT + (26/30)PT14 ADP-heptose-LPS
heptosyltransferase I
A911_05490
“ ATC + (21/30)PT14 Molybdate
ABC-transporter
A911_01445
“ CTT + (21/30)PT14 Spermidine/putrescine
ABC-transporter
A911_03575
“ GAA + (21/30)PT14 Glycosyltransferase A911_05505
TTTTACCGTCTAAAATTTCATTTTTTTCAA 4.5 × 10−4 TTA + (26/30)PT14 Isocitrate dehydrogenase A911_02585
AAGGGGTTGGCTTTTTGGATTCTTTTTTAA 4.5 × 10−4 TAA + (26/30)PT14 nusG Transcription
antiterminator
A911_02310
TTTTTTCTTTATTTTAAAATTTTTAATCTA 4.5 × 10−4 TTA (22/30)PT14 Intergenic A911_03110
aPartial spacer sequence matches to the PT14 chromosome are indicated in bold. Nucleotide substitutions in the acquired spacer 3 sequences are underlined.
bThe frequency with respect to invariant spacer 1 sequence reads mapping to the CRISP array.
cPAM is the observed proto-spacer adjacent tri-nucleotide sequence.
dTarget strand indicates whether the spacer binds the coding (+) or non-coding (−) DNA strands of PT14.
results in a transcriptional start site 4 nucleotides into the fol-
lowing spacer (Figure 2). However, RNAseq data generated from
rRNA depleted RNA indicates transcription within the C. jejuni
PT14 CRISPR array also arises within the second spacer using a
similar -10 nucleotide motif of 5′-TAAAAT-3′. Treatment with 5′-
monophosphate-dependent exonuclease (TEX) further revealed
that this transcription start site dominates transcription within
the CRISPR region, some 15-fold greater than the transcription
start sites distal to the direct repeats (Figure 2). The dominant
start site is located 7 nucleotides before direct repeat 3, which
would favor the expression of the 3′-end of spacer 2 and spacer 3.
THE ACQUISITION OF SPACERS IN CARRIER STATE CULTURES
The carrier state of C. jejuni is characterized by the association
of host bacteria with bacteriophages in an equilibrium state such
that the viable count to the phage titer ratio are maintained
upon serial propagation (Siringan et al., 2014). Carrier state cul-
tures PT14CP8CS and PT14CP30ACS were passaged five times
using mass inoculums on blood agar plates to represent at least
100 generations of Campylobacter in association with the cor-
responding Class III bacteriophages (CP8 or CP30A). Genomic
DNAs were prepared from these cultures with similarly treated
wild type C. jejuni PT14, from which 5 to 7 million sequence
reads were collected for each sample using the MiSeq platform.
DNA sequence reads that contained flanking direct repeats were
selected and examined for nucleotide changes in the intervening
spacer sequences or for the acquisition of new spacer sequences
within the C. jejuni PT14 CRISPR array. New spacer sequences
were identified from the carrier state cultures but not PT14.
The carrier state populations of PT14CP8CS and PT14CP30ACS
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FIGURE 2 | Organization and transcription of the CRISPR-array of
C. jejuni PT14. The CRISPR array is located between moe2 (A911_07320)
and cas2 (A911_07325). The plot shows log2 cDNA read counts from libraries
constructed from TEX treated C. jejuni PT14 RNA mapped to the CRISPR
array. The relative positions of direct repeats are indicated as black squares,
the spacers as green diamonds (spacers 1–3) and the tracrRNA in gold.
Transcription start sites are marked by black arrows where the greater
transcription arising from spacer 2 indicated by the width of the arrow. The
−10 nucleotide motifs with respect to the transcription start sites are
indicated adjacent to the arrows for the spacer 2 and the tracrRNA, and those
common to the direct repeats below the black squares. The position of
spacer acquisition in the carrier state cultures is indicated below (spacer 4).
contained bacteria that had extended the CRISPR array by either
acquisition of an additional copy of spacer 3 or naive spacer
sequences (indicated as spacer 4 in Figure 2). In all cases the
spacer acquisitions were positioned adjacent to spacer 3 toward
the distal end of the array, and were of a uniform length of 30
nucleotides as are the native spacers. Nucleotide changes were
centered on the additional spacer 3 DNA sequence and flank-
ing direct repeats whilst spacer sequences 1 and 2 remained fixed.
Table 1 documents the nucleotide sequence changes observed in
the additional copy of spacer 3 and the naive sequences acquired
by the carrier state cultures. Notably all the naive spacer DNA
sequences could be mapped to the host genome sequence and
were not represented in either of the co-propagating bacterio-
phage genomes.
DISCUSSION
The presence of a Cas4-like protein in Campylobacter bac-
teriophages represents another unexpected twist in the co-
evolutionary pathway with their hosts. The maintenance of the
protein throughout Class II and Class III Campylobacter phages
suggests that the activity confers a selective advantage. Whilst
significant divergence in overall amino acid sequence identity is
observed between the two phage classes, the conserved cysteine
residues and signature motifs of Cas4 proteins are all present.
This poses the question as to how the Cas4-like proteins in
Campylobacter bacteriophages operate, whether these proteins
have a defined role in phage infection and/or enable the phages
to exert control over their host bacteria. Type II CRISPR-Cas
systems show flexibility in their arrangement with Cas9 being
divorced from Cas2 in 31 of 103 reported examples (Makarova
et al., 2011). Further evidence for the modular assembly of Type
II CRISPR-Cas systems has been proposed for Csn2 that has an
analogous role to Cas4 in the integration spacer sequences in sub-
type II-A systems. Phylogenetic analysis of Cas1 and Cas9 proteins
reveals the subtype II-A branch to be embedded within subtype
II-C protein sequences, which implies that the subtype II-A sys-
tem is a derivative of the subtype II-C, and that Csn2 has been
acquired later (Chylinski et al., 2014). Subtype II-B systems con-
tain Cas4 orthologs, however the addition of phage encoded Cas4
to the subtype II-C system does not phylogenetically resemble a
subtype II-B system. Subtype II-B systems are reported to origi-
nate from type I CRISPR-Cas systems with respect to their Cas1,
Cas2, and Cas4 protein sequences and CRISPR repeats (Chylinski
et al., 2014). The configuration of a subtype II-C with the phage
encoded copy of Cas4 represents a new combination. The ability
of phage encoded Cas4 to modify spacer element acquisition in a
host subtype II-C system could potentially allow the phage influ-
ence the content of the CRISPR array in an attempt to evade or
subvert interference.
The carrier state of C. jejuni provided an opportunity to exam-
ine the operation of the CRISPR-Cas system in the presence
of Class III bacteriophage carrying Cas4. Carrier state cultures
derived from C. jejuni PT14 that propagate either bacterio-
phage CP8 or CP30 were selected on the basis of their ability
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to maintain near constant viable count to bacteriophage titer
ratios, and on the observed genomic stability of the bacterium and
bacteriophage (Siringan et al., 2014). As a pre-requisite we exam-
ined transcription within the CRISPR array of C. jejuni PT14
using RNASeq data. The CRISPR array of C. jejuni PT14 con-
tains 4 direct repeats interspersed with 3 spacer sequences of 30
nucleotides, where each spacer has the potential for independent
expression based on promoter sites located within the preceding
direct repeat. This arrangement is consistent with the organi-
zation and transcription of other CRISPR-containing C. jejuni
strains (Brathwaite et al., 2013). However, spacer 2 of C. jejuni
PT14 contains an additional strong promoter that results in
strong expression of the 3′-end of spacer 2 and spacer 3. Pairing
of tracrRNA with the preceding direct repeat would leave an 8
nucleotide overhang from the spacer 2/direct repeat boundary of
5′-AACACUGG-3′. Whether 8 nucleotides is a sufficient guide to
locate the Cas9-containing complex is not clear but the sequence
has the potential to pair with 10 sites within the PT14 genome, 1
within CP8 (encoding the DNA end protector) and 2 with CP30
(encoding the DNA end protector and peptidase). Maturation
of the major transcript originating within spacer 2 by RNase III
cleavage produces abundant spacer 3 crRNA.
Type II CRISPR-Cas systems are generally reported to bind
and cleave DNA through the action of Cas9 (Jinek et al., 2012),
and it is clear that targeting of chromosomal sequences will be
detrimental leading to either cell death or genome rearrangement
(Vercoe et al., 2013). However, examples exist whereby partial
base-pairings to crRNAs do not result in DNA cleavage (Jinek
et al., 2012) but rather have the potential to alter gene expres-
sion. For example, partial pairing of crRNA to Mu-like prophage
gene 42 of Pseudomonas aeruginosa does not result in cell death
or confer phage resistance but results in Cas-interference depen-
dent modulation of swarming behavior and biofilm formation
that is likely mediated by crRNA binding mRNA to cause anti-
sense inhibition (Zegans et al., 2009; Cady et al., 2012). Two of the
native spacer sequences of C. jejuni PT14 have partial sequence
matches that could influence the expression of cell surface com-
ponents and therefore bacteriophage recognition and entry. The
nucleotide sequences of spacer 1 and the 5′-end of spacer 2 have
the potential to pair respectively with mRNA encoding outer
membrane lipoprotein Omp18 (A911_00540) and apolipopro-
tein N-acyltransferase (A911_05300). Transcription of the gene
encoding apolipoprotein N-acyltransferase is barely detectable in
C. jejuni PT14, which would influence the presentation of acy-
lated lipoproteins and enable the strain to evade recognition by
Toll-like receptors (TLR) 1/2 and any resulting pro-inflammatory
response. TLR 1/2 signaling is a significant component of the
pro-inflammatory response to C. jejuni by human cell lines (Al-
Sayeqh et al., 2010). However, the antisense crRNAs to Omp18
and apolipoprotein N-acyltransferase are weakly expressed in
comparison with spacer 3 that has 15-fold greater expression
but limited self-recognition and almost no sequence similarity to
Class III bacteriophages CP8 and CP30.
We initiated this study to examine the influence of bacterio-
phage encoded Cas4 on spacer acquisition. The presence of bacte-
riophages in the carrier state indeed resulted in spacer acquisition
but all the spacers were of host origin. Bacteriophage protospacers
were not targeted despite continued replication of the bacterio-
phage. Whether bacteriophage protospacers are preferentially not
recognized or do not become fixed in the CRISPR array is unclear
but the properties of bacteriophage DNA by which it could evade
protospacer selection include base modification or the presence
of protective protein-DNA interactions. The function of Cas4
in spacer acquisition is the generation of ssDNA 3′-ends that
enable strand invasion-mediated incorporation into the CRISPR
array. The most abundant acquired spacer represents the reinte-
gration of an additional copy of spacer 3. The presence of flanking
sequences in the paired sequence reads enabled the new spacer 4
to be located at the distal end of the array in what appears to be
a relatively frequent process (1 in 16 relative to the read count
recorded for spacer 1). This is in contrast to in vivo studies with
Streptococcus thermophiles, which indicate that spacers are added
at the leader end of the CRISPR array and lost from the distal
end such that new spacers are added at the expense of old ones
in response to new challenges (Deveau et al., 2008). Similarly it
is reported that spacer acquisition occurs at the leader end of
Escherichia coli BL21 upon over-expression Cas1 and Cas2, and
where the disruption of spacer transcription does not to prevent
acquisition (Yosef et al., 2012). Using this systemmutations intro-
duced into the first repeat were observed to be propagated during
spacer acquisition indicating that the proximal repeat acts as the
template for subsequent generations of the repeat sequence (Yosef
et al., 2012). However, the first direct repeat of C. jejuni CRISPR-
arrays contains a 5′-terminal nucleotide substitution compared
to all the subsequent repeats that was not propagated during the
acquisition process. Inspection of the acquired spacer 4 sequences
and flanking direct repeats reveals sequence reads containing sin-
gle nucleotide substitutions that extend proximal to the major
transcription start site located seven nucleotides within spacer 2,
and distal to the final direct repeat. Before and after this loca-
tion the sequence reads are conserved. Degeneration of the direct
repeat is a feature of subtype II-B CRISPR systems that also use
Cas4 in their integration mechanism. It is tempting to suggest
that the resumption of sequence conservation marks the bound-
aries on the resolution of the recombination complex responsible
for introducing the new spacer and that the single nucleotide
substitutions mark repair sites following Cas4-mediated strand
invasion.
The deep sequencing strategy employed in this study allows
even rare molecular events to be recorded but provides no evi-
dence as to the fitness of the resulting bacteria or whether they
even survive. By definition the CRISPR array is a target for crRNA
but since wild type C. jejuni array sequences are maintained,
these must be either exempt or actively surveyed and repaired
to insure against CRISPR-directed DNA cleavage. Expansion of
the CRISPR array with an existing spacer may benefit from
pre-existing protective mechanisms; however the acquisition of
ectopic chromosomal sequences is likely to increase the risk of
CRISPR-mediated autoimmunity (Stern et al., 2010). Self-derived
spacer-acquisition has been reported to occur repeatedly, and in
the majority of cases lead to cell death (Yosef et al., 2012). We
have observed the acquisition of naive self-spacer sequences in
the CRISPR arrays of carrier state C. jejuni, and unlike the native
spacer DNA sequences many of these show near or complete
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sequence identity with host chromosomal genes. The high degree
of sequence conservation may reflect the recent acquisition of
these sequences, and as stated above we cannot determine how
long the bacteria carrying these spacers survive. It is possible
that CRISPR-mediated autoimmunity is maintained in this con-
text as an altruistic response to persistent bacteriophage infection
but if this were the case it does not explain why the bacterio-
phage should maintain a functional component of the system. It
is possible that the bacteriophage mobilize host-spacer acquisi-
tion as a decoy to prevent phage DNA acquisition, and therefore
the expression of Cas4 is an anti-CRISPR measure. Escape of
CRISPR-mediated autoimmunity can occur through mutation
of components of the host CRISPR-Cas system including the
cas genes, spacers, repeats or protospacer targets if not essential
(Vercoe et al., 2013). Loss of a functional CRISPR-Cas would
leave the bacteria open to horizontal gene transfer since nat-
ural transformation is common in the genus, with the long
term consequence of genome homogenization and erosion of
genome features that would formerly differentiate the bacte-
ria. It is reported that C. coli are subject to introgression from
C. jejuni as both inhabit the intestinal tract of commercial poultry
(Sheppard et al., 2008). CRISPR-mediated autoimmunity could
therefore be profoundly directing the shape of evolution in these
species.
The fate of the infected host during the lytic life cycle of
the bacteriophage would have no impact on the reproductive
success of the bacteriophage. However, under the specialized cir-
cumstances that give rise to the carrier state life cycle, then the
acquisition of host spacers could be detrimental to the continued
survival of the host and the bacteriophage. In these experiments
we cannot deduce if self-spacer acquisition can provoke muta-
tion but we note the multiple occurrence of the same spacer
sequence and independent targeting of proto-spacers within the
same gene or genes of related function amongst the naive spacer
sequences acquired. These observations may be due to bias in
the adaptation mechanism or due to bacterial replication and
selection post-spacer acquisition. It is also possible the expression
of the crRNAs themselves are altering bacterial gene expression,
which would provide a reason for the multiple acquisition of
spacers targeting proto-spacers in the same genes or those of
related function and another reason for the bacteriophage to
maintain Cas4 in order to subvert and/or reprogram the host
bacteria to pave the way to the carrier state under conditions
which otherwise would lead to low replicative success of the bac-
teriophage. Antisense transcription is not abnormal in C. jejuni
with a recent high resolution survey reporting that 45% of the
transcriptional start sites direct antisense transcription in mul-
tiple strains (Dugar et al., 2013). C. jejuni can certainly tolerate
antisense expression but may also use the process as a form of
gene regulation since campylobacters are generally noted for their
minimal quota of regulatory genes. In this context we note the
acquisition of spacers that produce crRNAs that could act as
antisense RNA inhibitors/modulators, for example the CRISPR-
associated protein Cas8c/Csd1 and three independent spacers
targeting ADP-heptose-lipo-oligosaccharide heptosyltransferase
systems. Heptosyl residues form a link that enables decoration
of lipo-oligosacharides in C. jejuni, the absence of which would
prevent further carbohydrate addition that includes Gal-GalNac-
NeuAc moieties that are also associated with human ganglioside
types involved in the GM1 or GD1 molecular mimicry asso-
ciated with Guillian-Barre syndrome and severe gastro-enteritis
(Godschalk et al., 2007; Mortensen et al., 2009). It has been sug-
gested that lipo-oligosacharide sialylation represents a defense
mechanism that protects C. jejuni from bacteriophage infec-
tion (Louwen et al., 2013), which would be abrogated by
preventing the expression of ADP-heptose-lipo-oligosaccharide
heptosyltransferase.
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